Given the lack of selectivity vs. individual dimers, both polypeptides and small molecules can inhibit the activity of the AP-1 complex not only in cancer cells, in which Fra-1 is a major component, but also in normal tissues, expressing at physiological levels a large variety of AP-1 homo- and hetero-dimers. Here, JUND is linked to cancer.